Regorafenib (BAY 73-4506): a new oral multikinase inhibitor of angiogenic, stromal and oncogenic receptor tyrosine kinases with potent preclinical antitumor activity

WILHELM Scott M.; DUMAS Jacques; ADNANE Lila; LYNCH Mark; CARTER Christopher A.; SCHUETZ Gunnar; THIERAUCH Karl-Heinz; ZOPF Dieter

Art

J-GLOBAL ID：201202275145582624 Reference number：12A0918021

Regorafenib (BAY 73-4506): a new oral multikinase inhibitor of angiogenic, stromal and oncogenic receptor tyrosine kinases with potent preclinical antitumor activity

レゴラフィニブ (BAY 73-4506): 強力な前臨床抗腫瘍活性を備えた血管原性・間質性・発癌性の受容体チロシンキナーゼの新規経口マルチキナーゼ阻害剤

Publisher site Copy service {{ this.onShowCLink("http://jdream3.com/copy/?sid=JGLOBAL&noSystem=1&documentNoArray=12A0918021&COPY=1") }}
Access JDreamⅢ for advanced search and analysis. {{ this.onShowJLink("http://jdream3.com/lp/jglobal/index.html?docNo=12A0918021&from=J-GLOBAL&jstjournalNo=A0267B") }}

Author (8)： , , , , , , ,
Material：
Volume： 129 Issue： 1 Page： 245-255 Publication year： Jul. 01, 2011
JST Material Number： A0267B ISSN： 0020-7136 Document type： Article
Country of issue： United States (USA) Language： ENGLISH (EN)

, , , , , ,

Return to Previous Page